title: Complete, long-standing regression of hepatocellular carcinoma after somatostatin analogue treatment.
authors.forename: Gabriel
authors.initials: G
authors.lastname: Rahmi
authors.forename: David
authors.initials: D
authors.lastname: Malka
authors.forename: Gorana
authors.initials: G
authors.lastname: Tomasic
authors.forename: Clarisse
authors.initials: C
authors.lastname: Dromain
authors.forename: Michel
authors.initials: M
authors.lastname: Ducreux
authors.forename: Valérie
authors.initials: V
authors.lastname: Boige
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000097:blood / Q000000981:diagnostic imaging / Q000188:drug therapy*; D006801:Humans; D008113:Liver Neoplasms / Q000097:blood / Q000000981:diagnostic imaging / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D015282:Octreotide / Q000627:therapeutic use*; D014057:Tomography, X-Ray Computed; D000509:alpha-Fetoproteins / Q000032:analysis
chemical_list: D018931:Antineoplastic Agents, Hormonal; D000509:alpha-Fetoproteins; D015282:Octreotide